CLINICAL_TRIALS
trial_result
· 2012-07-23
Clinical Trial Update: Study of Dasatinib in Children and Adolescents With Relapsed or Refractory Leukemia [Phase 1]
Summary
Phase 1 trial of dasatinib in children and adolescents with relapsed or refractory leukemia has completed with results posted in 2012.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Bristol-Myers Squibb | Conditions: Leukemia | Phase 1 | Status: COMPLETED | Results posted: 2012-07-23